Over 1500 Exhibitors From 40 Countries Showcase Their Products

Over 1500 Exhibitors From 40 Countries Showcase Their Products

Over the past five years, India has become the leading API and finished dose drug exporter to the Western markets and has rapidly moved up the pharmaceutical value chain. Drug approvals given by the US Food and Drug Administration (USFDA) to Indian companies have nearly doubled from 109 (2014-2015) to 201 (2015-2016), stimulating further growth in exports to the United States and Western economies. Additionally, the Indian government is now providing more support working hand-in-hand with its businesses to develop incentives to further boost growth. More generally, the country is now rapidly emerging as a major contributor across the pharma supply chain from R&D through to generics.

With this regards, India’s leading B2B exhibition organizer, UBM, brought in the 11th edition of the signature event, CPhI and P-MEC India, one of the world’s leading pharma networking expos. Spread across two locations, this year’s edition saw more than 1500 exhibitors and participation from over 40 countries.

The Southeast Asia’s largest Pharma event was held at MMRDA Grounds, Bandra Kurla Complex from November 27 -to 29 and Bombay Exhibition Centre from November 28- to 30.

Alongside the expo, UBM India launched the second edition of the India Pharma Week (IPW), an attractive platter of more than ten trend-setting events that got off to a flying start on November 25. Focusing on the pillars of business, knowledge, leadership, innovation, recognition and networking in the pharma domain, the IPW included a Plant Visit, Pharma Leaders’ Golf, Pre-Connect Congress, Women in Pharma – Power Breakfast, the India Pharma Awards, Networking Evening, a closed door CEO Roundtable and many more activities.